Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| Buy | $2.4K | SEC | |
| Buy | $1.7K | SEC | |
| Buy | $6.2K | SEC | |
| Exercise | $532K | SEC | |
| ExerciseD | $0 | SEC | |
| Other | $444.5K | SEC | |
| ExerciseD | $0 | SEC | |
| Other | $789.1K | SEC | |
| Exercise | $273.9K | SEC | |
| Buy | $882 | SEC | |
| Buy | $35K | SEC | |
| Buy | — | SEC | |
| Buy | — | SEC | |
| Buy | — | SEC | |
| Buy | — | SEC | |
| Buy | — | SEC | |
| Buy | — | SEC | |
| AwardD | — | SEC | |
| Buy | — | SEC | |
| Buy | — | SEC | |
| Buy | — | SEC | |
| Buy | — | SEC | |
| Buy | — | SEC | |
| Buy | — | SEC | |
| Buy | — | SEC |